Lentivirus-Mediated Rnai Knockdown of Insulin- Like Growth Factor-1 Receptor Inhibits the Growth and Invasion of Hepatocellular Carcinoma Via Down-Regulating Midkine Expression

Cai Qun Bie,Xu You Liu,Ming Rong Cao,Qiu Yan Huang,Hui Jun Tang,Min Wang,Guo Li Cao,Ting Zhuang Yi,Sheng Lan Wu,Wei Jie Xu,Shao Hui Tang
DOI: https://doi.org/10.18632/oncotarget.13027
2016-01-01
Oncotarget
Abstract:The insulin-like growth factor-1 receptor (IGF-1R) overexpression contributes to the development of a variety of cancers. The present study explored the role of IGF-1R in the development and progression of hepatocellular carcinoma (HCC) and the possibility of IGF-1R silencing by lentivirus-mediated RNA interference (RNAi) as a therapeutic target for HCC. We showed that IGF-1R mRNA was up-regulated in Huh7 and Hep3B cells and human HCC tissues, and that IGF-1R knockdown by RNAi led to decreased proliferation, apoptosis induction, and decreased migration and invasion of Huh7 and Hep3B cells. Further, the in vivo study indicated that IGF-1R knockdown markedly diminished the tumorigenesis and metastasis of Huh7 xenograft. Moreover, the intratumoral administration of lentivirus-IGF-1R siRNA led to significant tumor growth inhibition in an established Huh7 xenograft model. Mechanistic investigations showed that midkine was found to be the most significantly down-regulated protein in Huh7 cells with IGF-1R knockdown, and ectopic overexpression of midkine significantly rescued inhibition of Huh7 cell proliferation, migration, and invasion caused by IGF-1R suppression. Collectively, these data suggest that IGF-1R inhibition by RNAi can significantly suppress HCC growth and invasion at least partially through down-regulating midkine expression, and IGF-1R is a potential target for HCC gene therapy.
What problem does this paper attempt to address?